Logo image of WELL-DB.CA

WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Overview

Canada - TSX:WELL-DB - CA94947LAC69

100.4 CAD
0 (0%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to WELL-DB. WELL-DB was compared to 15 industry peers in the Health Care Providers & Services industry. While WELL-DB seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, WELL-DB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

WELL-DB had negative earnings in the past year.
WELL-DB had a positive operating cash flow in the past year.
In multiple years WELL-DB reported negative net income over the last 5 years.
Of the past 5 years WELL-DB 4 years had a positive operating cash flow.
WELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

With a Return On Assets value of -6.37%, WELL-DB is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Equity of WELL-DB (-15.57%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -6.37%
ROE -15.57%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL-DB.CA Yearly ROA, ROE, ROICWELL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

WELL-DB has a Gross Margin (39.21%) which is in line with its industry peers.
WELL-DB's Gross Margin has improved in the last couple of years.
WELL-DB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL-DB.CA Yearly Profit, Operating, Gross MarginsWELL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

4

2. Health

2.1 Basic Checks

WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL-DB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WELL-DB has been increased compared to 5 years ago.
WELL-DB has a better debt/assets ratio than last year.
WELL-DB.CA Yearly Shares OutstandingWELL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL-DB.CA Yearly Total Debt VS Total AssetsWELL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

WELL-DB has an Altman-Z score of 13.26. This indicates that WELL-DB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of WELL-DB (13.26) is better than 100.00% of its industry peers.
WELL-DB has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL-DB is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.68, WELL-DB is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 13.26
ROIC/WACCN/A
WACC8.07%
WELL-DB.CA Yearly LT Debt VS Equity VS FCFWELL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

WELL-DB has a Current Ratio of 0.93. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WELL-DB (0.93) is better than 66.67% of its industry peers.
A Quick Ratio of 0.92 indicates that WELL-DB may have some problems paying its short term obligations.
The Quick ratio of WELL-DB (0.92) is better than 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.92
WELL-DB.CA Yearly Current Assets VS Current LiabilitesWELL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The earnings per share for WELL-DB have decreased strongly by -221.43% in the last year.
WELL-DB shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.36%.
Measured over the past years, WELL-DB shows a very strong growth in Revenue. The Revenue has been growing by 94.78% on average per year.
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%

3.2 Future

The Earnings Per Share is expected to grow by 15.87% on average over the next years. This is quite good.
WELL-DB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.88% yearly.
EPS Next Y-80.96%
EPS Next 2Y3.84%
EPS Next 3Y13.5%
EPS Next 5Y15.87%
Revenue Next Year43.37%
Revenue Next 2Y25.55%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
WELL-DB.CA Yearly Revenue VS EstimatesWELL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL-DB.CA Yearly EPS VS EstimatesWELL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2

1

4. Valuation

4.1 Price/Earnings Ratio

WELL-DB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 620.74, WELL-DB can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as WELL-DB.
The average S&P500 Price/Forward Earnings ratio is at 22.73. WELL-DB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 620.74
WELL-DB.CA Price Earnings VS Forward Price EarningsWELL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

WELL-DB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. WELL-DB is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 382.69
WELL-DB.CA Per share dataWELL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as WELL-DB's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.84%
EPS Next 3Y13.5%

0

5. Dividend

5.1 Amount

WELL-DB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WELL HEALTH TECHNOLOGIES

TSX:WELL-DB (9/11/2025, 7:00:00 PM)

100.4

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap25.43B
Analysts81
Price Target164.44 (63.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)2.43%
PT rev (3m)-16.34%
EPS NQ rev (1m)26.08%
EPS NQ rev (3m)191.38%
EPS NY rev (1m)-86.98%
EPS NY rev (3m)-86.98%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)28.04%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)1.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 620.74
P/S 23.21
P/FCF N/A
P/OCF 5487.54
P/B 30.78
P/tB N/A
EV/EBITDA 382.69
EPS(TTM)-0.51
EYN/A
EPS(NY)0.16
Fwd EY0.16%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.02%
SpS4.33
BVpS3.26
TBVpS-2.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.37%
ROE -15.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.21%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 8.34
Cap/Depr 25.5%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 6.83%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.92
Altman-Z 13.26
F-Score2
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y-80.96%
EPS Next 2Y3.84%
EPS Next 3Y13.5%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.37%
Revenue Next 2Y25.55%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.94%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A